Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: jopawa who wrote (881)	1/15/1999 8:40:00 AM
From: John F Beule	Read Replies (1) \| Respond to of 2539

Can anyone help me with this one....Bloomberg this am mentioned a blurb to the effect that the new "super aspirins" increase the risk of heart problems. Is this political manuevering by Merck? John

To: jopawa who wrote (881)	1/15/1999 9:18:00 AM
From: Anthony Wong	Respond to of 2539

Monsanto's Bovine Growth Hormone Rejected by Canada, WSJ Says Bloomberg News January 15, 1999, 7:48 a.m. ET Ottawa, Jan. 15 (Bloomberg) -- Monsanto Co., one of the world's leading agricultural biotechnology companies, didn't win approval from the Canadian government for a bovine growth hormone because of concerns over the health of cows, the Wall Street Journal said. The hormone, which generates global revenue of $200 million a year, increases the milk production of cows by 10 percent to 15 percent and has been used in the U.S. since it was approved in 1994, the newspaper said. The Canadian government said the hormone was safe for humans, although it raised questions about the increased risk of udder infections in cows injected with the hormone, as well as infertility problems, the Journal said. The Washington-based advocacy group Center for Food Safety said last month that it's petitioning the U.S. Food and Drug Administration to review the agency's 1993 approval of the bovine growth hormone, citing human safety concerns. (WSJ 1/15 B6 www.wsj.com)